Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results

Autor: Ortu, Massimiliano, Vitiello, Paola, Adorni, Fulvio, Rossotti, Roberto, di Vincenzo, Paola, Viganó, Ottavia, Galli, Massimo, Rusconi, Stefano

Publikováno v: Current HIV research
9 (2011): 625–629. doi:10.2174/157016211798998790
info:cnr-pdr/source/autori:Ortu, Massimiliano; Vitiello, Paola; Adorni, Fulvio; Rossotti, Roberto; Rossotti, Roberto; di Vincenzo, Paola; di Vincenzo, Paola; Viganó, Ottavia; Galli, Massimo; Rusconi, Stefano/titolo:Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results/doi:10.2174%2F157016211798998790/rivista:Current HIV research (Print)/anno:2011/pagina_da:625/pagina_a:629/intervallo_pagine:625–629/volume:9
9 (2011): 625–629.
info:cnr-pdr/source/autori:Ortu, Massimiliano; Vitiello, Paola; Adorni, Fulvio; Rossotti, Roberto; Di Vincenzo, Paola; Vigano, Ottavia; Galli, Massimo; Rusconi, Stefano/titolo:Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results/doi:/rivista:Current HIV research (Print)/anno:2011/pagina_da:625/pagina_a:629/intervallo_pagine:625–629/volume:9

Background: Since recent observations demonstrated that extended resistance to protease inhibitors, nucleosidic and non - nucleosidic retrotranscriptase inhibitors (PI, NRTI, NNRTI) is a marker of disease progression and death, it is a matter of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1846792d718a4f8c2b78bbb6891c79e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.